Mana Capital Acquisition Corp.
MAAQR
NASDAQ Global Market0.56
USD
+0.05
- -
Mana Capital Acquisition Corp.
MAAQR
(NASDAQ Global Market)
Recent
price
0.56
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Mana Capital Acquisition Corp. (MAAQR) is a special purpose acquisition company (SPAC) sponsored by Mana Capital Group that focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses, with an emphasis on high-growth targets in digital assets, blockchain technology, decentralized finance (DeFi), fintech, healthcare, technology, green economy, and consumer products sectors. Incorporated in 2021 and headquartered in Dover, Delaware, the company completed its initial public offering in November 2021, raising $62 million in gross proceeds held in trust, and initially traded its units, common stock (MAAQ), warrants (MAAQW), and rights (MAAQR) on Nasdaq. As a blank check company, Mana Capital Acquisition offers no current products or services beyond its SPAC structure, including trust account management pending a de-SPAC transaction and public market access for target companies in North America, Europe, Asia, and potentially globally. In a major development, the company entered a definitive business combination agreement with Cardio Diagnostics, Inc. in May 2022, which closed on October 25, 2022, resulting in Mana Capital Acquisition merging with Cardio Diagnostics; the combined entity was renamed Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), with MAAQ and MAAQW transitioning to CDIO and CDIOW, while units (MAAQU) and rights (MAAQR) were delisted from Nasdaq on October 26, 2022. Post-merger, Mana Capital Acquisition ceased independent operations as a standalone SPAC, with MAAQR rights detached from the prior units and trading over-the-counter amid low volume and potential delisting risks, reflecting no further strategic shifts, acquisitions, partnerships, or funding rounds since the transaction.